1. Home
  2. UBXG vs MBRX Comparison

UBXG vs MBRX Comparison

Compare UBXG & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • MBRX
  • Stock Information
  • Founded
  • UBXG 2018
  • MBRX 2015
  • Country
  • UBXG China
  • MBRX United States
  • Employees
  • UBXG N/A
  • MBRX N/A
  • Industry
  • UBXG
  • MBRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • MBRX Health Care
  • Exchange
  • UBXG Nasdaq
  • MBRX Nasdaq
  • Market Cap
  • UBXG 38.2M
  • MBRX 23.5M
  • IPO Year
  • UBXG 2024
  • MBRX 2016
  • Fundamental
  • Price
  • UBXG $2.33
  • MBRX $0.46
  • Analyst Decision
  • UBXG
  • MBRX Strong Buy
  • Analyst Count
  • UBXG 0
  • MBRX 4
  • Target Price
  • UBXG N/A
  • MBRX $5.00
  • AVG Volume (30 Days)
  • UBXG 69.5K
  • MBRX 5.3M
  • Earning Date
  • UBXG 01-01-0001
  • MBRX 11-12-2025
  • Dividend Yield
  • UBXG N/A
  • MBRX N/A
  • EPS Growth
  • UBXG N/A
  • MBRX N/A
  • EPS
  • UBXG N/A
  • MBRX N/A
  • Revenue
  • UBXG $29,674,534.00
  • MBRX N/A
  • Revenue This Year
  • UBXG N/A
  • MBRX N/A
  • Revenue Next Year
  • UBXG N/A
  • MBRX N/A
  • P/E Ratio
  • UBXG N/A
  • MBRX N/A
  • Revenue Growth
  • UBXG N/A
  • MBRX N/A
  • 52 Week Low
  • UBXG $1.62
  • MBRX $0.25
  • 52 Week High
  • UBXG $6.04
  • MBRX $3.65
  • Technical
  • Relative Strength Index (RSI)
  • UBXG 58.19
  • MBRX 46.58
  • Support Level
  • UBXG $2.09
  • MBRX $0.43
  • Resistance Level
  • UBXG $2.30
  • MBRX $0.63
  • Average True Range (ATR)
  • UBXG 0.16
  • MBRX 0.05
  • MACD
  • UBXG 0.03
  • MBRX -0.00
  • Stochastic Oscillator
  • UBXG 61.93
  • MBRX 15.60

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: